164 related articles for article (PubMed ID: 6572566)
1. Induction of cytotoxic effector activity in the HL-60 promyelocytic cell line by incubation with phorbol myristate acetate: a model system of human spontaneous monocyte-mediated cytotoxicity.
Hall RE; Muchmore AV; Decker JM; Blaese RM
Cell Immunol; 1983 Feb; 76(1):58-68. PubMed ID: 6572566
[TBL] [Abstract][Full Text] [Related]
2. Two distinct cytolytic mechanisms of macrophages and monocytes activated by phorbol myristate acetate.
Chung T; Kim YB
J Leukoc Biol; 1988 Nov; 44(5):329-36. PubMed ID: 3183511
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of phorbol diester-induced HL-60-mediated cytotoxicity by retinoic acid, dimethyl sulfoxide, and 5-azacytidine.
Leftwich JA; Hall RE
Cancer Res; 1986 Aug; 46(8):3789-92. PubMed ID: 2425933
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation.
Dallegri F; Ballestrero A; Frumento G; Patrone F
Blut; 1986 Apr; 52(4):243-8. PubMed ID: 3008895
[TBL] [Abstract][Full Text] [Related]
5. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
[TBL] [Abstract][Full Text] [Related]
6. Chemotactic peptide enhancement of PMA triggered monocyte cytotoxicity.
Dallegri F; Patrone F; Ballestrero A; Frumento G; Sacchetti C
Clin Exp Immunol; 1984 Sep; 57(3):717-21. PubMed ID: 6467686
[TBL] [Abstract][Full Text] [Related]
7. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
Mavier P; Edgington TS
J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.
van Kessel KP; Visser MR; van Strijp JA; van Kats-Renaud JH; Verhoef J
Immunology; 1986 Jun; 58(2):291-6. PubMed ID: 3710525
[TBL] [Abstract][Full Text] [Related]
9. Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.
Klassen DK; Conkling PR; Sagone AL
Infect Immun; 1982 Mar; 35(3):818-25. PubMed ID: 7068217
[TBL] [Abstract][Full Text] [Related]
10. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
11. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
Hall RE; Muchmore AV; Blaese RM
J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of phorbol myristate acetate on human natural killer cell activity.
Abrams SI; Bray RA; Brahmi Z
Cell Immunol; 1983 Sep; 80(2):230-40. PubMed ID: 6411354
[TBL] [Abstract][Full Text] [Related]
13. Rapid and reversible modulation of T4 (CD4) on monocytoid cells by phorbol myristate acetate: effect on HIV susceptibility.
Firestein GS; Reifler D; Richman D; Gruber HE
Cell Immunol; 1988 Apr; 113(1):63-9. PubMed ID: 3365771
[TBL] [Abstract][Full Text] [Related]
14. Oxidative mechanisms of monocyte-mediated cytotoxicity.
Weiss SJ; LoBuglio AF; Kessler HB
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):584-7. PubMed ID: 6244567
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of tumour cell destruction by PMA-activated human neutrophils.
Dallegri F; Frumento G; Patrone F
Immunology; 1983 Feb; 48(2):273-9. PubMed ID: 6295926
[TBL] [Abstract][Full Text] [Related]
16. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous cytotoxicity by human peripheral blood monocytes: inhibition by monosaccharides and oligosaccharides.
Muchmore AV; Decker JM; Blaese RM
Immunobiology; 1981; 158(3):191-206. PubMed ID: 6260628
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
19. Tumoricidal activity of an acute promyelocytic leukemia cell line (HL-60) is augmented by human interferon alpha.
Buessow SC; Gillespie GY; Mahaley MS
Leuk Res; 1984; 8(5):801-11. PubMed ID: 6593510
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones.
Bensussan A; Tourvieille B; Chen LK; Dausset J; Sasportes M
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6642-6. PubMed ID: 3876559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
